Differential effect of histamine 3 receptor-active agents on brain, but not peritoneal, mast cell activation - PubMed (original) (raw)

. 1999 Sep;290(3):1427-35.

Affiliations

PMID: 10454522

Differential effect of histamine 3 receptor-active agents on brain, but not peritoneal, mast cell activation

J J Rozniecki et al. J Pharmacol Exp Ther. 1999 Sep.

Abstract

The activation of presynaptic histamine 3 (H(3)) receptors inhibits the release of histamine and other neurotransmitters from central nervous system neurons. Rat brain mast cells (MCs) release histamine and 5-hydroxytryptamine (5-HT) in response to neuropeptides and neurotransmitters secreted from adjacent neurons. Dura MCs also degranulate in response to antidromic trigeminal nerve stimulation and with acute psychological stress. Such findings have implicated brain MCs in certain neuroinflammatory disorders, such as migraines. We investigated the ultrastructural appearance of control and stimulated thalamic/hypothalamic (brain) MCs before and after treatment with the H(3) receptor agonist N(alpha)-methylhistamine (N(alpha)-mH) and the H(3) receptor antagonist thioperamide (Th). Ultrastructural investigation of brain MCs stimulated with compound 48/80 revealed extensive intragranular changes that paralleled 5-HT secretion but without degranulation by exocytosis typical of connective tissue MCs. N(alpha)-mH significantly reduced these morphological changes, as well as 5-HT release from brain MCs and neurons stimulated with KCl; conversely, Th augmented both histamine and 5-HT release from brain neurons and MCs. Neither N(alpha)-mH nor Th had any effect on peritoneal MCs. Simultaneous addition of both drugs largely antagonized each other's effects on brain MC activation and 5-HT secretion. Ultrastructural observations and lack of lactic dehydrogenase release in the perfusate excluded any cytotoxic effect. The ability of H(3) agonists to inhibit brain MC activation, as well as secretion of 5-HT from both brain MCs and neurons, may be useful in the management of migraines.

PubMed Disclaimer

Cited by

Novel identified receptors on mast cells.
Migalovich-Sheikhet H, Friedman S, Mankuta D, Levi-Schaffer F. Migalovich-Sheikhet H, et al. Front Immunol. 2012 Aug 2;3:238. doi: 10.3389/fimmu.2012.00238. eCollection 2012. Front Immunol. 2012. PMID: 22876248 Free PMC article.
Histamine Receptors Regulate the Activity, Surface Expression, and Phosphorylation of Serotonin Transporters.
Annamalai B, Ragu Varman D, Horton RE, Daws LC, Jayanthi LD, Ramamoorthy S. Annamalai B, et al. ACS Chem Neurosci. 2020 Feb 5;11(3):466-476. doi: 10.1021/acschemneuro.9b00664. Epub 2020 Jan 22. ACS Chem Neurosci. 2020. PMID: 31916747 Free PMC article.
Histamine and migraine revisited: mechanisms and possible drug targets.
Worm J, Falkenberg K, Olesen J. Worm J, et al. J Headache Pain. 2019 Mar 25;20(1):30. doi: 10.1186/s10194-019-0984-1. J Headache Pain. 2019. PMID: 30909864 Free PMC article. Review.
Chondroitin sulphate inhibits connective tissue mast cells.
Theoharides TC, Patra P, Boucher W, Letourneau R, Kempuraj D, Chiang G, Jeudy S, Hesse L, Athanasiou A. Theoharides TC, et al. Br J Pharmacol. 2000 Nov;131(6):1039-49. doi: 10.1038/sj.bjp.0703672. Br J Pharmacol. 2000. PMID: 11082109 Free PMC article.
New concepts of histamine receptors and actions.
Repka-Ramirez MS. Repka-Ramirez MS. Curr Allergy Asthma Rep. 2003 May;3(3):227-31. doi: 10.1007/s11882-003-0044-3. Curr Allergy Asthma Rep. 2003. PMID: 12662472 Review.

Differential effect of histamine 3 receptor-active agents on brain, but not peritoneal, mast cell activation - PubMed (original) (raw)